secretariat - indonesian society of hypertension · secretariat perki house building 2nd floor ......

Indonesian Society of Hypertension

SecretariatPERKI House Building 2nd floor

Jl. danau Toba 139 A-C, Bendungan Hilir - Jakarta Pusat, IndonesiaPhone: (62-21) 573-4978, Fax: (62-21) 573-4978

Email: www.inash.or.idWebsite: www.inash.or.id

FINAL ANNOUNCEMENT

Dear Colleagues and Friends

It is a great pleasure, on behalf of the Indonesian Society of Hypertension, to welcomeyou all to this 7th Indonesian Hypertension Society Scientific Meeting.

In the years to come the burden of hypertension is expected to rise enormously.There were approximately 972 million people living with high blood pressure in theworld in the year 2000, compared to an estimated 1.56 billion in 2025, and inIndonesia approximately 31,7 % adult people living with hypertension.

Efforts to control the epidemic of high BP and its cardiovascular and renal complicationshave traditionally focused on pharmacologic treatment of persons with establishedhypertension. Such efforts reflect an impressive body of evidence that has documentedthe beneficial effects of antihypertensive drug therapy in preventing BP-related clinicalcomplications.

We realized that drug therapy alone is an incomplete solution to the treatment ofhigh BP and its complications. It is well recognized that the risk of BP-relatedcardiovascular and renal disease increases progressively throughout the range ofBP, including ranges of BP previously considered normal. Hypertension is not alwaysa physiological problem and it can also be caused due to various kinds of mentalproblems that disturb the mind

Furthermore, a large fraction of adults have a BP that is above optimal and yet isbelow the traditional threshold for drug treatment. Such BP levels nonetheless placeindividuals at increased risk of BP-related complications, yet they are not candidatesfor drug therapy. In view of these considerations, national and international policy-making bodies recommend lifestyle modification as a means to prevent and treathypertension and thereby prevent cardiovascular and renal disease in the wholepopulation.To concentrate on the above mentioned difficulties, our theme this meeting is

“Hypertension - Related Problems : Management and the Future Prospects”

Thank you, and we look forward to seeing you in this hopefully fruitfull event.

Best regards,

Maruhum Bonar Marbun, MDChairman, Organizing CommitteeThe 7th Scientific Meeting ot the Indonesian Society of Hypertension

1

7th Indonesian Hypertension Society Scientific Meeting

PatronsPresident of Indonesian Society of Hypertension

President of Indonesian Heart AssociationPresident of Indonesian Neurological Association

President of Indonesian Society of Nephrology

2

Organizing Committee

Chairman:Maruhum Bonar Marbun, MD

Co-Chairman:Yuda Turana, MD

Secretary I:BRM Ario Soeryo, MD

Treasurer:Rossana Barack, MD

Ekawatidani Yulianti, MD

Scientific Section

Chairman:Arieska Ann Soenarta, MD

Members:Nani Hersunarti, MD

Santoso Karo Karo, MDAntonia Anna Lukito, MD

Adre Mayza, MDSuhardjono, MD

Tunggul Diapari Situmorang, MDPringgodigdo Nugroho, MD

Eka Harmeiwaty, MDDjoko Wibisono MD

Ni Made Hustrini, MD

Registration:Amanda Tiksnadi, MDNurhayana Lubis, MD


3

Acomodation:Frits R.W. Suling, MD

Rarsari Soerarso Pratikto, MD

Exhibition, Publication & Documentation:Rahmat Hidayat, MD

Yohanna Kusuma, MD

Business Meeting:Adrianus Kosasih, MD

Heru Kusumanto

Workshop:Siska Suridanda Danny, MDPringgodigdo Nugroho, MD

Amanda Tiksnadi, MD

How to SessionDafsah A. Juzar, MD

InaSH Guideline

Chairman:A. Sari S. Mumpuni, MD

Member:Yuda Turana, MD

Yohanna Kusuma, MDMaria Riastuti MD

Lydia Simatupang, MDSiska Suridanda Danny, MD

Press ConferenceAdrianus Kosasih, MD

Heru Kusumanto


4

PROGRAM AT GLANCETHE 7TH SCIENTIFIC MEETING ON HYPERTENSIONRitz Carlton Hotel Jakarta22-24 February 2013

PRE CONGGRESS

FRIDAY, 22 FEBRUARY 2013

TIMEWORKSHOP 1

MUTIARA 1WORKSHOP 2MUTIARA 2 & 3

WORKSHOP 3MUTIARA 6 & 7

Clinical, Home andAmbulatory BloodPressure Monitoring:The Usefullness inClincal Practice

Hypertension BrainScreen: Opthalmology,Imaging and CognitiveEvaluation

Renal SecondaryHypertension09.00-16.00

FRIDAY, 22 FEBRUARY 2013

09.00 - Finished Business Meeting Of InaSH Tulip Room


5


TIME

08.00 - 09.00

SATURDAY, 23 FEBRUARY 2013

BALLROOM 1 BALLROOM 2 GRAND MUTIARA

09.00 - 09.30

09.30 - 10.00

10.00 - 11.15

11.15 - 12.15

12.15 - 13.15

13.15 - 14.30

14.30 - 15.50

15.50 - FINISHED

Symposium 1

Lunch Symposium 1

Symposium 4

Symposium 7

Plenary Session 1

Opening Ceremony

Coffee Break

Door Prize

Symposium 5

Symposium 8

Symposium 2

Lunch Symposium 2

Lunch

Symposium 3How to Session 1

Lunch Symposium 3




6


TIME

07.30 - 08.30

SUNDAY, 24 FEBRUARY 2013

BALLROOM 1 BALLROOM 2 GRAND MUTIARA

08.30 - 09.30

09.30 - 10.45

10.45 - 11.15

11.15 - 12.15

12.15 - 13.15

13.15 - 14.15

14.15 - 14.30

14.30 - 15.00

Symposium 10

Breakfast Symposium 1

Plenary Session 2

Distribution Consensus

Symposium 15

Symposium 11

Lunch Symposium 5

Lunch


Lunch Symposium 4

Breakfast Symposium 2

Coffee Break


Young InvestigatorAward

Launching Consensus, Closing Remarks and Door Prize


Scientific ProgramFriday, February 22, 2013

7

WORKSHOP

WORKSHOP I : CLINICAL, HOME AND AMBULATORYBLOOD PRESSURE MONITORING:THE USEFULLNESS IN CLINICAL PRACTICE

Course Coordinator : Siska Suridanda Danny, MD

09.00 - 09.30 : REGISTRATION & MORNING COFFEE

09.30 - 09.45 : Pretest

09.45 - 10.00 : OPENING AND INTRODUCTIONSiska Suridanda Danny, MD

10.00 - 10.30 : Ambulatory Blood Pressure and Home Blood Pressure:Overview of Evidence vs Guidelines PerspectivesSiska Suridanda Danny, MD

10.30 - 11.00 : Blood Pressure Variability in Cardiovascular Risk Stratification:Does it Matter Much?BRM. Ario Soeryo Kuncoro, MD

11.00 - 11.30 : White-coat, Masked and Resistant Hypertension: Role ofAmbulatory and Home Blood Pressure MonitoringAdrianus Kosasih, MD

11.30 - 13.00 : FRIDAY PRAYING & LUNCH

13.00 - 13.30 : ABPM: Reading and InterpretationArieska Ann Soenarta, MD

13.30 - 14.30 : Case DiscussonFaculty

14.30 - 15.30 : Skill stationPreparation and Equipment SettingCase Discussion/ Interpretation

15.30 - 15.45 : Post test

15.45 - 16.00 : Adjourned

16.00 - Finish Closing remarksSiska Suridanda Danny, MD

Mutiara 1


8

WORKSHOP II : HYPERTENSIVE BRAIN SCREEN:OPTHALMOLOGY, IMAGING ANDCOGNITIVE EVALUATION

Course Coordinator : Amanda Tiksnadi, MD

09.00 - 09.30 : REGISTRATION

09.30 - 09.45 : Pre Test

09.45 - 10.00 : OPENING AND INTRODUCTIONAmanda Tiiksnadi, MD

10.00 - 10.45 : Cognitive and Behaviour AssesmentDr. Diatri Nari Lastri, Sp.S(K)

10.45 - 11.30 : Neuro ImagingMelita, MD


13.00 - 15.15 : Hands - on & Case Discussion

15.15 - 15.30 : Post test

15.30 - Finish : Closing RemarksAmanda Tiksnadi, MD

Mutiara 2 & 3


9

WORKSHOP III : RENAL SECONDARY HYPERTENSION

Course Coordinator : Pringgodigdo Nugroho, MD


09.30 - 09.40 : Pre test

09.40 - 09.50 : OPENINGPringgodigdo Nugroho, MD

09.50 - 10.20 : Epidemiology, Risk Factor and Etiology of SecondaryHypertensionLucky Aziziah, MD

10.20 - 10.50 : Who should be Evaluated for Secondary Hypertension?Ginova Ninggolan, MD

10.50 - 11.20 : Workup and Evaluation of Patient with Secondary HypertensionI Gde Raka Widiana, MD


13.00 - 13.30 : Treatment Overview for Secondary HypertensionEndang Susalit, MD

13.30 - 14.00 : DISCUSSION

14.00 - 15.45 : Case DiscussonHaerani Rasyid, MD

15.45 - 16.00 : Post test

16.00 - Finish : Closing RemarkPronggodigdo Nugroho, MD

Mutiara 6 & 7


10


PLENARY SESSION I

Chairman : Prof. Rully M.A. Roesli, MD, PhD

08.00 - 08.30 : Government Policies in Controling Hypertension in Indonesia Tjandra Yoga Adhitama, MD

08.30 - 09.00 : Future of Hypertension Management : Challenges for BetterOutcome in Hypertension and Kidney - Vice VersaMurray Esler, MD

09.00 - 09.30 : OPENING CEREMONY

09.30 - 10.00 : COFFEE BREAK

SYMPOSIUM 1

MOVING BEYOND EFFECTIVE HYPERTENSION MANAGEMENT

Chairman : Santoso Karo Karo, MD

10.00 - 10.20 : How to Achieve Compliance in Hypertension PopulationSyakib Bakrie, MD

10.20 - 10.40 : Dual Combination in Hypertension Management: Which & forWhom?Dante D. Morales, MD

10.40 - 11.00 : Beyond FPG, PPG and HB A1C - MAGE Reduction in Relationto Cardiovascular Risk Protection.

Slamet Suyono, MD

11.00 - 11.15 : Discussion

Ballroom 2

Scientific ProgramSaturday, February 23, 2013

Ballroom 1


11

SYMPOSIUM 2

NEW PARADIGM IN HYPERTENSION MANAGEMENT FOR BETTERRESULTS

Chairman : Prof. Wiguno Prodjosudjadi, MD

10.00 - 10.20 : What to do Beyond Lowering BP Values: Do Risk FactorsInfluence Morbidity Outcomes?Aida Lydia, MD

10.20 - 10.40 : Fixed Dose Combination CCB and ARB in Achieving BP Controlto Treat Hypertension

Zulkhair Ali, MD

10.40 - 11.00 : What's New in the Management of High Risk HypertensivePatients

Sutomo Kasiman, MD

11.00 - 11.15 : Discussion

SYMPOSIUM 3 HOW TO SESSION 1

THE ESSENTIAL ASPECTS OF HYPERTENSION

Chairman : Andang Joesoef, MD

10.00 - 10.20 : Pathophysiology of HypertensionPringgodigdo Nugroho, MD

10.20 - 10.41 : Classification and Cardiovascular Risk Assessment inHypertension

Frits RW Suling, MD

10.40 - 11.00 : Measuring Blood Pressure Ekawati Dani Yulianti, MD

11.00 - 11.16 : Discussion

Ballroom 2

Grand Mutiara


12

LUNCH SYMPOSIUM I

OPTIMIZING HYPERTENSION MANAGEMENT IN CLINICAL PRACTICE

Chairman : Teguh A.S Ranakusuma, MD

11.15 - 11.35 : Hypertension Management : When Experience Meets theEvidence

Ria Bandiara, MD

11.35 - 11.55 : Hypertension Management : Possible Role of Heart RateReductionErwinanto, MD

11.15 - 12.15 : Discussion

LUNCH SYMPOSIUM 2

LEADING THE RE-VOLUTION: STROKE PREVENTION IN PATIENTS WITHATRIAL FIBRILATION DIFFERENT PERSPECTIVES AND PRACTICALAPPROACHES

Chairman : Budi Baktijasa Dharmadjati, MD

11.15 - 11.35 : Navigating a Changing Landscape: What Factors Should WeConsider When Choosing an Anticoagulant for Stroke Preventionand How Can We Rely on RE-LY & RELY-ABLE?Trisulo Wasyanto, MD

11.35 - 11.15 : Choosing the Right Path: Supporting Evidence of DabigatranEtexilate and its Optimization for Usage in Clinical PracticeEka Harmeiwaty, MD, MD

11.15 - 12.15 : Discussion

Ballroom 1

Ballroom 1


13

LUNCH SYMPOSIUM 3

TARGETS IN LIPID AND DIABETES MANAGEMENT AS A PART OFMETABOLIC SYNDROME

Chairman : Pudji Rahardjo, MD

11.15 - 11.35 : Rationale for Using Combination Therapies in Lipid ManagementStrategiesYan Herry, MD

11.35 - 11.55 : Sitagliptin vs Sulfonylureas : Determining the Perfect Partnerwith MetforminPradana Soewondo, MD

11.55 - 12.15 : Discussion

12.15 - 13.15 : LUNCH

SYMPOSIUM 4

TREATING HYPERTENSION IN SPECIFIC POPULATION: NEW PARADIGM

Chairman : Eko Antono, MD

13.15 - 13.35 : Disruption of Cholesterol Homeostasis in The Brain: Its Role inDegenerative DisordersHasan Sjahrir, MD

13.35 - 13.55 : Updates on Indonesia Dyslipidaemia Guidelines & New EmergingHigh Risk Groups: The AlgorithmJohn Adam, MD

13.55 - 14.15 : Optimizing Lipid Treatment to Achieve Early CV Benefit: FromMolecular to Clinical Outcomes BlockersDjanggan Sargowo, MD

14.15-14.30 : Discussion

Grand Mutiara

Ballroom 1


14

SYMPOSIUM 5

THE CURRENT AND FUTURE HYPERTENSION MANAGEMENT INSPECIAL CONDITION

Chairman : Tunggul Diapari Situmorang, MD

13.15 - 13.35 : Acute Ischemic Stroke and Hypertensive Crisis: Pathopysiologicaland Therapeutical AspectsHasan Machfoed, MD

13.35 - 13.55 : Current Challenges in the Clinical Management of Hypertension A.Sari S. Mumpuni, MD

13.55 - 14.15 : Renal Sympathetic Nerve Hyperactivity in Chronic KidneyDiseases - the Role of ARBChandra Irwanadi Mohani, MD

14.15 - 14.30 : Discussion


MANAGEMENT OF HYPERTENSION 1

Chairman : Yuda Turana, MD

13.15 - 13.35 : Identifying Hypertension SyndromeLestariningsih, MD

13.35 - 13.55 : Pharmacological Management of HypertensionAmanda Tiksnadi, MD

13.55 - 14.15 : Exercise and HypertensionBasuni Radi, MD

14.15 - 14.31 : Discussion

Grand Mutiara

Ballroom 2


15

SYMPOSIUM 7

HYPERTENSION IN SPECIFIC CONDITION

Chairman : Iwan Dakota, MD

14.30 - 14.50 : Risk Stratification: Asian PerspectiveDante Morales, MD

14.50 - 15.10 : Blood Pressure Control in Acute Intra Cerebral Hemorrhage NV. Ramani, MD

15.10 - 15.30 : Prolong Holter / Cardiac Monitoring in Acute StrokeNV. Ramani, MD

15.30 - 15.50 : Discussion

SYMPOSIUM 8

ENDOTHELIUM AS THE LINK BETWEEN HYPERTENSION AND VASCULARDISEASE

Co-Chairman: Airiza Achmad, MD

14.30 - 15.00 : The Sympathetic Nervous System: A Short History from ThomasWillis to Radiofrequency Ablation of the Renal SympatheticNerves in Hypertension

Murray Esler, MD

15.00 - 15.30 : The Future of Renal Denervation Rests on Selecting the RightPatientMark Thomas, MD

15.30 - 15.50 : Discussion

Ballroom 1

Ballroom 2


16


MANAGEMENT OF HYPERTENSION 2

Chairman : Abdulbar Hamid, MD

14.30 - 14.50 : Managing Resistant HypertensionDafsah A. Juzar, MD

14.50 - 15.10 : Hypertension with Erectile Dysfunction : How to Cope? Sahala Panggabean, MD

15.10 - 15.30 : Diet and HypertensionMeilani Kumala MS, MD

15.30 - 15.50 : Discussion

15.50 - 16.15 : DOOR PRIZE

Grand Mutiara

Ballroom 2


17

BREAKFAST SYMPOSIUM I

THE SIGNIFICANT RELATION OF HYPERTENSION, THE BRAIN, HEARTAND KIDNEY

Chairman : Djoko Wibisono, MD

07.30 - 07.55 : Cardiorenal Protection Approach in Treating Hypertension Antonia Anna Lukito, MD

07.55 - 08.10 : Hypertension and Vascular Cognitive Impairment Adre Mayza, MD

08.10 - 08.30 : Discussion

BREAKFAST SYMPOSIUM 2

CARDIOVASCULAR RISK FACTORS - FOCUS ON DIABETES &DYSLIPIDEMIA: TWO MAJOR CONCERN IN OUR DAILY PRACTICE

Chairman : H.MS. Markum, MD

07.30 - 07.55 : The Ideal Partner to Manage Type 2 DM with DPP4 Inhibitor:What's new?Soebagjo Adi, MD

07.55 - 08.10 : The Importance of Potent Statin in Managing DiabeticDyslipidemia PatientsPradana Tedjasukmana, MD

08.10 - 08.30 : Discussion

Ballroom 2

Scientific ProgramSUNDAY, FEBRUARY 24, 2013

Ballroom 1


18

PLENARY SESSION 2

Chairman : Arieska Ann Soenarta, MD

08.30 - 09.00 : ISF Ranti Memorial Lecturer Asikin Hanafiah, MD

09.00 - 09.30 : Gene Polimorphism in Hypertension: Present and FuturePerspective

Brian Tomlinson, MD

SYMPOSIUM 10

PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITHHYPERTENSION AND DIABETES

Chairman : Maruhum Bonar Marbun, MD

09.30 - 09.50 : Treatment of Systemic and Intracranial Hypertension inHypertensive EncephalopathyMursyid Bustami, MD

09.50 - 10.10 : New Paradigm to Deal with Diabetes-Hypertensive Patients Imam Subekti, MD

10.10 - 10.30 : Moving Towards Early Hypertension Treatment with DoubleDigit BP ReductionRubin Surachno Gondodiputro, MD

10.30 - 10.45 : Discussion

Ballroom 1

Ballroom 2


19

SYMPOSIUM 11

NEW TREND TO PREVENT THROMBOEMBOLISM IN HYPERTENSIVEPATIENT

Chairman : Jose Roesma, MD

09.30 - 09.50 : Antiplatelet Agent in the Prevention of Atherotrombotic Stroke:a Critical ReviewFreddy Sitorus, MD

09.50 - 10.10 : RAAS Inhibitors in the Management of Hypertension Yogiarto, MD

10.10 - 10.30 : New Insight of Dyslipidemia Management - the Role of NewHMG-CoA Reductase InhibitorKetut Suwitra, MD

10.30 - 10.45 : Discussion


APPROACH FOR HYPERTENSION IN SPECIAL POPULATIONS 1

Chairman : Manfaluthi Hakim, MD

09.30 - 09.50 : Approach for Hypertension in Stroke Victims Yohanna Kusuma, MD

09.50 - 10.10 : Approach for Hypertension in Chronic Kidney DiseaseBambang Purwanto, MD

10.10 - 10.30 : Approach for Hypertension in Chronic Heart FailureRarsari Soerarso Pratikto, MD

10.30 - 10.45 : Discussion

10.45 - 11.15 : COFFEE BREAK

Grand Mutiara

Ballroom 2


20

LUNCH SYMPOSIUM 4

THE CHALLENGE OF STROKE PREVENTION: PRACTICAL SOLUTIONSTO IMPROVE PATIENT OUTCOMES

Chairman : Arieska Ann Soenarta, MD

11.15 - 11.30 : Hypertension and Atrial Fibrilation: The Connection? Hendro Susilo, MD

11.30 - 11.45 : The Importance of Pharmacotherapy in Atrial Fibrilation: ClinicalEvidence and Guideline?Ahmad Fauzi Yahya, MD

11.45 - 12.15 : Discussion

LUNCH SYMPOSIUM 5

LANDSCAPE OF COMBINATION THERAPY: WHICH WAY FORWARD?

Chairman : Nurjaman Nurimaba, MD

11.15 - 11.30 : ACE Inhibition, the Sine Qua Non of Combination Therapy Bambang Budi Siswanto, MD

11.30 - 11.45 : Antihypertensive Combination Therapy Beyond Brachial BPLowering EfficacySuhardjono, MD

11.45 - 12.15 : Discussion

Ballroom 1

Ballroom 2


21


APPROACH FOR HYPERTENSION IN SPECIAL POPULATIONS 2

Chairman : Ganesja M Harimurti, MD

11.15 - 11.30 : Approach for Hypertension in ElderlyThamrin Syamsuddin, MD

11.30 - 11.45 : Approach for Hypertension in PregnancyRossana Barack, MD

11.45 - 12.00 : Approach for Hypertension in Children and AdolesenceEka Laksmi Hidayati, MD

12.00 - 12.15 : Discussion

12.15 - 13.15 : LUNCH

SYMPOSIUM 14

YOUNG INVESTIGATOR AWARD

Grand Mutiara

Ballroom 1


22

SYMPOSIUM 15

INTERACTIVE CASE DISCUSSION THE COLLABORATION IN FIGHTINGHYPERTENSION AND ITS COMPLICATIONS

Co-Chairman: Pranawa Martosuwignyo MD

13.15 - 13.30 : Neurologist PerspectiveAndradi Suryamiharja, MD

13.30 - 13.45 : Nephrologist PerspectiveDharmeizar, MD

13.45 - 14.00 : Cardiologist PerspectiveNani Hersunarti, MD

14.00 - 14.15 : Discussion

14.15-14.30 : LAUNCHING AND DISTRIBUTIONInaSH ConsensusA. Sari S. Mumpuni, MD

14.30-15.00 : CLOSING REMARKS and DOOR PRIZES

Ballroom 2

Ballroom 2


23

CALL FOR ABSTRACTS

SUBMISSION CLOSING DEADLINE: 30 January 2013

Delegates are invited to submit abstracts for poster presentations. We only acceptresearch studies related to the main topic of the congress.

Abstract submission according to the instruction below and will be acknowledgedvia email reply directly upon received. Abstracts submission via fax will not beaccepted. No abstracts will be considered after closing deadline.

Presenting authors will receive notification of abstracts acceptance via email at

the latest before 10 February 2013. Evaluation by the Scientific Review Committeewill be based on quality, clarity and relevance for the main topic of the congress.

The Scientific Review Committee will select 3 abstracts to be presented at theScientific Oral Presentation session. Prizes will be awarded for 3 best oralpresentation and 3 best poster presentation.

All presenting authors, whose abstracts are accepted, must be paid registrants.Abstracts will not be processed until appropriate registration fee has been received.

The Organizing Committee has a right reserve to edit the format of abstracts forpublication on terms of uniformity purpose.

ABSTRACT SUBMISSION INSTRUCTIONS

• Abstracts must be typed in English.

• Abstracts are typed in Arial Font Size 12 with single one half spacing. All typingmust fit within the line (justify) and leave no margin at the top of lest side.

• All abstracts must be submitted by email to: [email protected] [email protected], attention to: SCIENTIFIC REVIEW COMMITTEE along withpersonal data as follow: Presenting author's full name, Institution affiliation &city and country origin, topic title.

• Maximum words should be at least 100 words and not exceed 300 words(not including title and authors information).

• Please organize the abstract contents as the following subtitles: Introductionmethodology, result, conclusions and keyword. Place a single blank line betweensubtitles.

• Do not use table or graphics in abstracts. All data must be in narrative form.


24

REGISTRATION FORM

Receipt Date: Registration Number:

Please type or print in BLOCK LETTER and tick (Ã) where applicableð Prof ð Dr ð Mr ð Mrs ð Ms

First Name: Surname:

Occupation: ð Specialist ð General Practitioner ð Nurse

ð Student ð Accompanying Person ( Non Medic)

Institution:

Mailing Address:

City / Zip Code: Phone: Fax: Email:

Phone:Contact Person:Sponsor:

Registration Fee :

Category BeforeJanuary 1, 2013

Start onJanuary 1, 2013

General Practitioner

Ina-SH member

Student/Nurse

Accompanying person (non medic)

ð Rp 1,000,000,-

ð Rp 900,000,-

Specialist

Ina-SH member

ð Rp 700,000,-

ð Rp 1,200,000,-

ð Rp 1,100,000,-

ð Rp 1,200,000,-

ð Rp 1,100,000,-

ð Rp 1,500,000,-

ð Rp 1,300,000,-

ð Rp 700,000,-

ð Rp 600,000,- ð Rp 600,000,-

Signature: Amount:

Policy of Registration:– Starting from January 12, 2013, we can only accept changing or substitution of

the Participant names and there willl be no refund for any registration payment.

– Starting February 1st ,2013, we will no longer accept for any changing or revisionof participant's data.

Payment should be made to:

ð Bank Mandiri KCP Jkt RS Harapan Kita117-00-0616009-7a/n Rossana Barack / Ekawati Dani Yuli


25

WORKSHOP REGISTRATION FORM

Receipt Date: Registration Number:





Institution:

Mailing Address:



Registration Fee :

WORKSHOP OnFriday, February 22,2013

BeforeJanuary 1, 2013

Start onJanuary 1, 2013

Signature: Amount:

Policy of Registration:– Starting from January 12, 2013, we can only accept changing or substitution of

the Participant names and there willl be no refund for any registration payment.

– Starting February 1st ,2013, we will no longer accept for any changing or revisionof participant's data.



ð Rp 1,500,000,-

ð Rp 1,500,000,-

ð Rp 1,500,000,-

ð Rp 1,350,000,-

ð Rp 1,350,000,-

ð Rp 1,350,000,-

1. Home and Ambulatory Monitoring:the Usefullnes in Clinical Practice

2. Hypertensive Brain Screen:Opthalmology, Imaging andCognitive Evaluation

3. Renal Secondary Hypertension


27





Institution:

Mailing Address:



Signature: Amount:

Policy of Reservation Hotel:– All cancellations or substitution of reservation must be notified in writing to

the 7th InaSH Annual Meeting Secretariat before January 18, 2013– There will be no refund all cancellation from January 18, 2013– Please contact the 7th InaSH Annual Meeting Secretariat for name replacements, changes of

the Room type and notifying check in / out date of hotel reservation prior to February 8, 2013



The Ritz Carlton Hotel, Jakarta

Room Rate net / night(incl. breakfast)Room Type

ð Grand Room

ð Grand Tempus Room

ð Grand Club Room

ð Mayfair Suite Room Rp 4,300,000,-

Checkin

Checkout

TotalNight

Fully Booked

Fully Booked

Fully Booked

...........................

...........................

...........................

...........................

...........................

...........................

...........................

...........................

...........................

JW Marriott Hotel, Jakarta


ð Deluxe Room

ð Executive Room

ð Governer Room Rp 2,150,000,-

Checkin

Checkout

TotalNight

Fully Booked

Fully Booked

...........................

...........................

...........................

...........................

...........................

...........................

...........................

Intercontinental Hotel, Jakarta


ð Deluxe Room Rp 1,550,000,-

Checkin

Checkout

TotalNight

........................... ........................... ...........................

Mandarin Hotel, Jakarta


ð Superior Room

ð Deluxe Room

Rp 1,650,000,-

Rp 1,950,000,-

Checkin

Checkout

TotalNight

...........................

...........................

...........................

...........................

...........................

...........................


secretariat - indonesian society of hypertension · secretariat perki house building 2nd floor ......

Documents